Atherosclerosis in young Brazilians suffering violent deaths: a pathological study

Manoel Es Modelli1, Aurea S Cherulli, Lenora Gandolfi

  • 1Department of Post Graduate School of Health Sciences, University of Brasilia, Brasília, Brazil. manoelmodelli@gmail.com.

BMC Research Notes
|December 14, 2011
PubMed

Insights

Atherosclerosis, a precursor to heart disease, is prevalent in young Brazilians, with nearly all arteries showing lesions. Early intervention is crucial to prevent future sudden cardiac death.

Area of Science:

  • Cardiovascular Pathology
  • Public Health
  • Forensic Medicine

Background:

  • Atherosclerosis is a primary cause of cardiovascular diseases and sudden death.
  • While traditionally associated with middle age, atherosclerosis development begins in childhood.
  • This study investigates early-stage atherosclerosis in young individuals.

Purpose of the Study:

  • To determine the prevalence and extent of atherosclerotic lesions in young Brazilians.
  • To analyze pathological alterations in major arteries of young victims of violent death.

Main Methods:

  • Examined carotid artery, coronary artery, and thoracic aorta samples from 100 young victims (12-33 years) of violent death.
  • Graded lesions using American Heart Association histological criteria.
  • Correlated findings with demographic data.

Main Results:

  • 97.34% of all examined arteries showed some degree of atherosclerosis.
  • Type II lesions (foam cells) were most common.
  • No normal thoracic aorta specimens were found; coronary arteries exhibited the highest atherosclerosis burden.

Conclusions:

  • A high prevalence of atherosclerotic lesions exists in young Brazilians.
  • Urgent interventions are needed to reduce sudden cardiac death rates in the adult population.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...